Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. DrugBank Drug (Description in trials) KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1 Desmopressin [5] DDAVP; Desmopressin; Desmopressin acetate; Desmopressine; Minirin[1] D00291 [2] AVPR2,
F8 💬		[4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[6] 6, 64, 72, 75, 225, 288
2 Empagliflozin [2] Empagliflozin; Jardiance[1] D10459 [1] SLC5A2 💬-[6] 58, 65, 67, 72, 97, 257
3 Exenatide [3] BYDUREON; Byetta; EXENATIDE[1] D04121 [1] GLP1R 💬[3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[6] 6, 17, 72, 78, 193, 233
4 Melatonin [2] Circadin; MELATONIN[1] D08170 [2] MTNR1A,
MTNR1B 💬		[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬[12] 6, 8, 13, 37, 46, 49, 72, 78, 90, 97, 145, 202
5 Oxytocin [2] OXYTOCIN; Syntocinon[1] D00089 [1] OXTR 💬[4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬[7] 6, 72, 127, 168, 193, 206, 226
6 Satavaptan [1] Satavaptan---[1] 72
7 Tolvaptan [3] Jinarc; Samsca; Tolvaptan[1] D01213 [1] AVPR2 💬[3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[4] 67, 72, 86, 225
8 Urea [1] Urea[2] D00023 ,
D01749 		--[2] 72, 251